Search for other papers by L E Zijlstra in
Google Scholar
PubMed
Search for other papers by D M van Velzen in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
Search for other papers by S P Mooijaart in
Google Scholar
PubMed
Department of Internal Medicine, HagaHospital, The Hague, The Netherlands
Search for other papers by M van Buren in
Google Scholar
PubMed
Search for other papers by D J Stott in
Google Scholar
PubMed
Search for other papers by I Ford in
Google Scholar
PubMed
Search for other papers by J W Jukema in
Google Scholar
PubMed
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by S Trompet in
Google Scholar
PubMed
increasing thyroid-stimulating hormone (TSH) levels and increased risk of stroke, high circulating free thyroxin (fT4) and increased risk of atrial fibrillation, and subclinical hypo- and hyperthyroidism and increased risk of coronary heart disease and
Search for other papers by Melinda Kertész in
Google Scholar
PubMed
Search for other papers by Szilárd Kun in
Google Scholar
PubMed
Search for other papers by Eszter Sélley in
Google Scholar
PubMed
Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed
Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed
Search for other papers by István Wittmann in
Google Scholar
PubMed
metabolic syndrome: a 50–80% increase in the risk of metabolic syndrome has been detected in the highest quartile compared to the lowest quartile of T3 level ( 13 ). Thus, both in non-diabetic and diabetic patients, HOMA-IR correlates with TSH, which
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
example is a paper by Sawin et al ., which showed a low serum thyrotropin (thyroid-stimulating hormone (TSH)) concentration in people aged 60 or older to be associated with a three times higher incidence of atrial fibrillation in the subsequent decade ( 6
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Xiao-qin Ge in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Yan Wang in
Google Scholar
PubMed
images, and biochemical indicators (each criterion must be met: low thyroid-stimulating hormone – TSH, high free triiodothyronine – FT3, high free thyroxine – FT4, elevated TSH receptor antibody – TRAb) ( 14 ). The exclusion criteria were as follows: (1
Search for other papers by Ning Yuan in
Google Scholar
PubMed
Search for other papers by Jianbin Sun in
Google Scholar
PubMed
Search for other papers by Xin Zhao in
Google Scholar
PubMed
Search for other papers by Jing Du in
Google Scholar
PubMed
Search for other papers by Min Nan in
Google Scholar
PubMed
Search for other papers by Qiaoling Zhang in
Google Scholar
PubMed
Search for other papers by Xiaomei Zhang in
Google Scholar
PubMed
Introduction Maternal subclinical hypothyroidism (SCH), which is defined as an increased thyroid-stimulating hormone (TSH) concentration beyond the upper limit of the pregnancy-specific reference range and a normal free-thyroxine (FT4
Search for other papers by Peter D Mark in
Google Scholar
PubMed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Claus L Petersen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Background Subclinical hyperthyroidism (SH) is defined by the biochemical pattern of reduced or undetectable serum thyroid-stimulating hormone (TSH) levels and thyroid hormone levels within the reference range. SH is seen with increasing frequency
Search for other papers by Jeonghoon Ha in
Google Scholar
PubMed
Search for other papers by Jeongmin Lee in
Google Scholar
PubMed
Search for other papers by Kwanhoon Jo in
Google Scholar
PubMed
Search for other papers by Dong-Jun Lim in
Google Scholar
PubMed
Search for other papers by Moo Il Kang in
Google Scholar
PubMed
Search for other papers by Bong Yun Cha in
Google Scholar
PubMed
Search for other papers by Min-Hee Kim in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is defined as a mildly elevated serum thyroid-stimulating hormone (TSH) level with a serum free thyroxine (FT4) level within the normal range ( 1 ). While treatment of SCH is not mandatory in most
Search for other papers by L Johnsen in
Google Scholar
PubMed
Search for other papers by N B Lyckegaard in
Google Scholar
PubMed
Search for other papers by P Khanal in
Google Scholar
PubMed
Search for other papers by B Quistorff in
Google Scholar
PubMed
Search for other papers by K Raun in
Google Scholar
PubMed
Search for other papers by M O Nielsen in
Google Scholar
PubMed
Rats Fetal undernutrition Adult ↓ Resting EE Subclinincal hypothyroid ( 15 ) Rats Maternal nutrient restriction, midlactation Adult – ↓ Serum T 4 and TSH ( 16 ) Rats Maternal nutrient restriction, late lactation
Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Yumei Jia in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
-Yang Hospital, Capital Medical University from March 2014 to January 2015. Meanwhile, 17 healthy volunteers without AIT were enrolled as the control group. Free T3 (FT3), free T4 (FT4), thyroid-stimulating hormone (TSH), anti-peroxidase antibody (TPOAb
Search for other papers by Leqi He in
Google Scholar
PubMed
Search for other papers by Xiaoying Li in
Google Scholar
PubMed
Search for other papers by Zaoping Chen in
Google Scholar
PubMed
Search for other papers by Wei Wang in
Google Scholar
PubMed
Search for other papers by Kai Wang in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
and stabilize at 5000–20,000 U/L in the second trimester of pregnancy ( 1 ). Because the subunit of hCG is similar to the α subunit of thyroid-stimulating hormone (TSH) ( 2 ), it can directly stimulate the TSH receptor and increase thyroid hormone